We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$134B
AUM Growth
+$14.8B
Cap. Flow
+$2.42B
Cap. Flow %
1.81%
Top 10 Hldgs %
25.29%
Holding
4,017
New
232
Increased
1,652
Reduced
1,816
Closed
191

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$219M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$157M
3
AMD icon
Advanced Micro Devices
AMD
+$131M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$102M
5
FANG icon
Diamondback Energy
FANG
+$90.5M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$124M
2
KEYS icon
Keysight
KEYS
+$84.3M
3
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$77.8M
4
UL icon
Unilever
UL
+$38.3M
5
ADBE icon
Adobe
ADBE
+$38M

Sector Composition

Rank Sector Weight
1 Technology 15.71%
2 Financials 9.02%
3 Healthcare 7.82%
4 Industrials 6.8%
5 Consumer Discretionary 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JVA icon
3751
Coffee Holding Co
JVA
$19.9M
$21.8K ﹤0.01%
24,000
– –
TELL
3752
DELISTED
Tellurian Inc.
TELL
$21.1K ﹤0.01%
27,971
-26,090
-48% -$18.5K
DWSN icon
3753
Dawson Geophysical
DWSN
$138M
$19.4K ﹤0.01%
10,593
– –
EVA
3754
DELISTED
Enviva Inc.
EVA
$19.4K ﹤0.01%
19,441
-19,142
-50% -$53.1K
AKTS
3755
DELISTED
Akoustis Technologies Inc
AKTS
$17.8K ﹤0.01%
21,391
+10,000
+88% +$6.72K
NGM
3756
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$17.8K ﹤0.01%
20,714
-1,209
-6% -$1.06K
DWTX
3757
Dogwood Therapeutics
DWTX
$61.9M
$17.3K ﹤0.01%
1,200
– –
LXRX icon
3758
Lexicon Pharmaceuticals
LXRX
$1.08B
$16.6K ﹤0.01%
10,841
– –
SKYX icon
3759
SKYX Platforms
SKYX
$165M
$16K ﹤0.01%
10,000
– –
LICY
3760
DELISTED
Li-Cycle Holdings Corp.
LICY
$15.8K ﹤0.01%
3,370
-3,263
-49% -$37.1K
SOHO
3761
DELISTED
Sotherly Hotels
SOHO
$14.9K ﹤0.01%
+10,000
New +$15.5K
VMAR icon
3762
Vision Marine Technologies
VMAR
$3.99M
– –
0
– –
CISO
3763
CISO Global
CISO
$11.8M
$14.3K ﹤0.01%
9,395
– –
AZ icon
3764
A2Z Smart Technologies
AZ
$298M
$13.7K ﹤0.01%
4,000
– –
FIGS icon
3765
CALL
FIGS
FIGS
$2.37B
$12.5K ﹤0.01%
+1,000
New +$6.62K
GEVO icon
3766
Gevo
GEVO
$403M
$12.4K ﹤0.01%
+10,700
New +$12.2K
NVTA
3767
DELISTED
Invitae Corporation
NVTA
$10.6K ﹤0.01%
16,843
-1,182
-7% -$707
ATRA icon
3768
Atara Biotherapeutics
ATRA
$80.6M
$10K ﹤0.01%
784
-6,802
-90% -$159K
VXRT
3769
DELISTED
Vaxart
VXRT
$9.73K ﹤0.01%
16,988
-500
-3% -$346
FTH
3770
Faeth Therapeutics
FTH
$773M
$9.69K ﹤0.01%
700
– –
POET icon
3771
POET Technologies
POET
$1.48B
$9.45K ﹤0.01%
+10,100
New +$17.7K
CRDL
3772
Cardiol Therapeutics
CRDL
$173M
$9.4K ﹤0.01%
+11,154
New +$9.48K
HYLN icon
3773
Hyliion Holdings
HYLN
$699M
$9.03K ﹤0.01%
11,100
-1,500
-12% -$1.06K
JOB icon
3774
GEE Group
JOB
$21.2M
$9K ﹤0.01%
18,000
– –
KGC icon
3775
CALL
Kinross Gold
KGC
$32.3B
$8.8K ﹤0.01%
2,200
– –
149 150
151
152 153

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Raymond James & Associates held 4,017 positions worth $134B, up 12% from $119B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q4 2023 filing shows 232 new, 1,652 increased, 1,816 reduced and 191 closed positions. Its largest new stake was Delek US: 515,324 shares worth $13.3M. The largest sale was Pioneer Natural Resource Co., an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2023 buy was Delek US: 515,324 shares worth $13.3M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $219M increase.
  • Raymond James & Associates's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $124M.
  • Raymond James & Associates fully exited Kayne Anderson NextGen Energy & Infrastructure, Inc. in Q4 2023, selling an estimated $22.8M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $134B portfolio in Q4 2023.
  • Raymond James & Associates opened 232 new positions and closed 191 in Q4 2023.
  • Raymond James & Associates's portfolio value rose 12% quarter-over-quarter to $134B.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.